Mike Rea and Tara Raveendran

Mike Rea is the founder of Protodigm, a next generation CRO that innovates, invents, develops, and prototypes possibilities for drugs to be brought to market, as well as the CEO and founder of IDEA Pharma, a specialist in pharmaceutical product positioning and path-to-market strategies. He has delivered positioning and strategy for eight of the fifteen biggest drug launches in the last five years. After having been named to The Medicine Maker’s Global Power List 100 from 2017 to 2019, in 2020 and 2021 he was added to the Global Power List 20: the top 20 inspirational medicine makers in biopharmaceuticals. PharmaPhorum has named him as one of the Top 10 Innovators in Pharma and PharmaVOICE awarded him with a lifetime Red Jacket as one of the 100 Most Inspiring People in Healthcare. He is the author of the Medical Marketing Manual: Branding Pharmaceuticals and the Pharmaceutical Innovation Index. Mike earned his bachelor’s degree in genetics from the University of Newcastle-upon-Tyne.

Tara Raveendran
Tara is the Principal at Protodigm where she oversees research and finance strategy for her clients. She helps clients at Protodigm navigate the complex capital market to emerge with a successful business solution. Tara comes from over fifteen years in the financial markets, specializing in European healthcare equity research. As a consultant she has worked with innovative life science start-ups, helping develop their market and shaping their capital raising strategy. She is highly experienced in analytical writing, equity analysis and financial modelling, in addition to having technical expertise. Tara’s strong hypothesis-driven approach to problem solving and decision-making stems from her academic background in science. She earned her B.Sc. in Biochemistry and Ph.D. in Structural Biology, from the Imperial College London.